rs201470386

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001145536.2(C17orf107):​c.*1360C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00205 in 1,607,600 control chromosomes in the GnomAD database, including 60 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 25 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 35 hom. )

Consequence

C17orf107
NM_001145536.2 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0550

Publications

0 publications found
Variant links:
Genes affected
C17orf107 (HGNC:37238): (chromosome 17 open reading frame 107)
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
CHRNE Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • congenital myasthenic syndrome 4A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • congenital myasthenic syndrome 4B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 4C
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-4901893-C-T is Benign according to our data. Variant chr17-4901893-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 254899.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0102 (1541/151474) while in subpopulation AFR AF = 0.0358 (1463/40816). AF 95% confidence interval is 0.0343. There are 25 homozygotes in GnomAd4. There are 710 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001145536.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C17orf107
NM_001145536.2
MANE Select
c.*1360C>T
3_prime_UTR
Exon 3 of 3NP_001139008.1Q6ZR85
CHRNE
NM_000080.4
MANE Select
c.500+39G>A
intron
N/ANP_000071.1Q04844

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C17orf107
ENST00000381365.4
TSL:2 MANE Select
c.*1360C>T
3_prime_UTR
Exon 3 of 3ENSP00000370770.3Q6ZR85
CHRNE
ENST00000649488.2
MANE Select
c.500+39G>A
intron
N/AENSP00000497829.1Q04844
C17orf107
ENST00000861085.1
c.*1360C>T
3_prime_UTR
Exon 3 of 3ENSP00000531144.1

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1539
AN:
151364
Hom.:
25
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0359
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00328
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00281
AC:
695
AN:
247416
AF XY:
0.00212
show subpopulations
Gnomad AFR exome
AF:
0.0362
Gnomad AMR exome
AF:
0.00229
Gnomad ASJ exome
AF:
0.000599
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000360
Gnomad OTH exome
AF:
0.00149
GnomAD4 exome
AF:
0.00120
AC:
1750
AN:
1456126
Hom.:
35
Cov.:
33
AF XY:
0.00102
AC XY:
738
AN XY:
724624
show subpopulations
African (AFR)
AF:
0.0391
AC:
1299
AN:
33182
American (AMR)
AF:
0.00239
AC:
107
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.000307
AC:
8
AN:
26090
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39628
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86054
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53036
Middle Eastern (MID)
AF:
0.00291
AC:
14
AN:
4818
European-Non Finnish (NFE)
AF:
0.000168
AC:
186
AN:
1108578
Other (OTH)
AF:
0.00208
AC:
125
AN:
60052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.603
Heterozygous variant carriers
0
69
138
206
275
344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1541
AN:
151474
Hom.:
25
Cov.:
32
AF XY:
0.00959
AC XY:
710
AN XY:
74056
show subpopulations
African (AFR)
AF:
0.0358
AC:
1463
AN:
40816
American (AMR)
AF:
0.00328
AC:
50
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
67992
Other (OTH)
AF:
0.00333
AC:
7
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
75
150
226
301
376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0154
Hom.:
12
Bravo
AF:
0.0114

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.2
DANN
Benign
0.88
PhyloP100
0.055
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201470386; hg19: chr17-4805188; API